• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

Innovate IndianaNews and information on how IU is driving innovation, entrepreneurship and economic development

IU researchers seek to commercialize AI tool to identify undiagnosed cases of early-stage Alzheimer’s disease and related dementia

Posted on January 24, 2023 by Ryan Piurek

Bri Heron, technology marketing manager at Indiana University’s Innovation and Commercialization Office, contributed the following story.

In the United States alone, Alzheimer’s disease currently affects 6.5 million people and over 11 million caregivers. National costs are projected to reach $1 trillion by 2050.

Malaz Boustani
Malaz Boustani

Current early detection approaches for Alzheimer’s disease and other forms of cognitive diseases are not standardized or scalable for urban and rural communities. Data also suggest that nearly 50 percent of patients with Alzheimer’s and other cognitive diseases are undiagnosed. For those that are diagnosed, it can take up to five years of multiple medical visits.

Indiana University researchers Malaz Boustani, the Richard M. Fairbanks Professor of Aging Research at the IU School of Medicine, and Zina Ben Miled, associate professor of electrical and computer engineering at IUPUI, are working together to tackle this issue by designing implementable, scalable and sustainable brain care solutions.

Together, Boustani and Ben Miled have developed and clinically validated an artificial intelligence tool for early identification of Alzheimer’s disease and related dementias. This technology was recently licensed through IU’s Innovation and Commercialization Office to DigiCARE Realized, a new AI-technology company focused on modernizing care in complex brain diseases.

“Early detection for cognitive diseases offers the opportunity for more timely diagnoses which leads to proactive care,” said Boustani, who is the chief innovation and implementation officer at the IU Center for Health Innovation and Implementation Science. “Given the recent FDA drug approval for the treatment of Alzheimer’s disease, early detection is even more essential.”

The DigiCARE Realized technology detects patients with undiagnosed Alzheimer’s disease and related forms of dementia, such as Lewy body dementia and frontotemporal dementia, with nearly 80 percent performance accuracy for ≤ 3-year prediction horizons.

Zina Ben Miled
Zina Ben Miled

When the DigiCARE Realized machine-learning technology is deployed in electronic medical records of a health system, it processes routinely collected structured and unstructured data. This technology has demonstrated the ability to review high volumes of patient health records in hours versus what would take clinicians days to review.

Boustani and Ben Miled have joined the founding team, which includes Brittany Cassin, CEO and co-founder of DigiCARE Realized.

“We believe that if you can measure it, you can manage it,” said Cassin. “For the first time, we can provide patient- and population-level data to a health system for better brain health insight. More importantly, we provide health systems the opportunity to deliver routine brain care for our growing, aging population that is feasible to implement across their network.”

Ben Miled emphasized that early detection is the first step to diagnosing in a timely manner.

Brittany Cassin
Brittany Cassin

“We trained our algorithm to rapidly comb through different types of data, including vast medical notes, found in electronic health records to recognize indicators and data patterns that can identify undiagnosed cases of Alzheimer’s disease and other forms of dementia,” Ben Miled said.

The algorithm was tested in different retrospective analysis with a NIH-sponsored prospective study underway. Peer-reviewed papers discussing the results have been published in the Journal of the American Geriatrics Society and in the Journal of Artificial Intelligence in Medicine.

Boustani said the IU Innovation and Commercialization Office helped translate his ideas into reality.

Digicare Realized logo“Translating innovation research to everyday use in clinical practice takes many different experts,” Boustani said. “The Innovation and Commercialization Office continues to be instrumental in collaborating with researchers and business partners to bring these innovative solutions to improve care for patients and their families.”

DigiCARE Realized is raising pre-seed funding to take its AI-enabled platform for early detection technology and care management through its first phase of commercialization. Learn more at digicarerealized.com.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Filed under: Engagement, Entrepreneurship, Faculty, IU Innovation and Commercialization Office, Research, Technology CommercializationTagged aging research, AI, Alzheimer's disease, artificial intelligence, Brittany Cassin, dementia, DigiCARE Realized, healthcare, healthcare innovation, IU Center for Health Innovation and Implementation Science, IU Innovation and Commercialization Office, IU School of Medicine, IUPUI, machine learning, Malaz Boustani, Zina Ben Miled

One Comment

  1. Mike Bilbao January 27th, 2023

    Fantastic! This is a constructive initiative to address & alleviate a growing challenge for our society!

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Innovate Indiana Button

Search Innovate Indiana

About Innovate Indiana

Join us as we highlight how IU innovation is accelerating economic growth in Indiana and beyond and creating a culture of entrepreneurship across the Hoosier state.

Innovate Indiana is maintained by the Indiana University Office of the Vice President for University Relations.

Recent Posts

  • IU School of Medicine researcher develops a novel, highly efficient method of producing retinal organoids March 14, 2023
  • Strengthening civics education in Indiana and beyond March 10, 2023
  • Hoosier hoops great Alan Henderson set to bring his new venture game back to Bloomington March 8, 2023
  • IU School of Medicine researcher develops non-invasive tool to detect mutations that could potentially lead to breast cancer February 24, 2023
  • IU, NSWC Crane partner on research initiative to help secure Navy's AI, machine learning systems February 1, 2023

Categories

Bookmarks

  • Innovate Indiana website
  • IU Center on Representative Government
  • IU Impact
  • IU Innovation and Commercialization Office
  • IU Office of the Vice President for Research
  • IU Office of the Vice President for University Relations
  • IU Ventures

Subscribe to the Innovate Indiana blog

Opt out at any time.

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.